MMsINC Database Search
logo   logo
logo Search | Help | MolPaint | Roadmap | Credits | Feedback


Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00713184

You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.


LigandLigand nameChainPDBTanimotoLigand in PDB
LigandLigand nameChainPDBTanimotoLigand in PDB
CH6{(4Z)-2-[(1S)-1-amino-3-(methylsulfanyl)propyl]-
4-[(4-hydroxyphenyl)methylidene]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A2H5Q0.71
CH6{(4Z)-2-[(1S)-1-amino-3-(methylsulfanyl)propyl]-
4-[(4-hydroxyphenyl)methylidene]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A1XQM0.71
CH6{(4Z)-2-[(1S)-1-amino-3-(methylsulfanyl)propyl]-
4-[(4-hydroxyphenyl)methylidene]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A,B2QLG0.71
CH6{(4Z)-2-[(1S)-1-amino-3-(methylsulfanyl)propyl]-
4-[(4-hydroxyphenyl)methylidene]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A1XA90.71
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
B,D2A540.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A3E5V0.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
B,D2A560.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
B,D2A530.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
B,D2A500.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A,B,G,H3CFH0.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A,B,C,D3E5W0.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A,B,C,D,E,F,
G,H
3BXC0.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A,B,G,H3CFF0.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A3E5T0.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A,B,C,D,E,F,
G,H
3BXB0.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
B,D2A520.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A,B2QLG0.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A,B3BXA0.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A,B,C,D,E,F,
G,H
2V4E0.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A,B2QLI0.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A,B1UIS0.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A,B,C,D,E,F,
G,H
1ZGQ0.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A,B,G,H3CFA0.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A,B2QLH0.72
NRQ{(4Z)-4-(4-hydroxybenzylidene)-
2-[3-(methylthio)propanimidoyl]-
5-oxo-4,5-dihydro-1H-imidazol-1-
yl}acetic acid
A,B3BX90.72
TYPCYCLO-(L-TYROSINE-L-PROLINE) INHIBITORA,B1W1Y0.7
HC4A1TS60.7
HC4A3PHY0.7
HC4A3PYP0.7
HC4A1T1C0.7
HC4A1OT60.7
HC4A1TS00.7
HC4A1T1A0.7
HC4A2PYP0.7
HC4A2ZOI0.7
HC4A1OTI0.7
HC4A1XFQ0.7
HC4A2D010.7
HC4A,B,C,D,E,F,
G,H
2O7B0.7
HC4A2ZOH0.7
HC4A1GSW0.7
HC4A2QJ70.7
HC4A1F9I0.7
HC4X1UWP0.7
HC4A2PHY0.7
HC4A1T1B0.7
HC4A1F980.7
HC4A1T190.7
HC4X1UWN0.7
HC4A,B,C,D,E,F,
G,H
2O7F0.7
HC4A1UGU0.7
HC4A1TS80.7
HC4A,B1OTD0.7
HC4A1OTE0.7
HC4A1GSX0.7
HC4A1TS70.7
HC4A2PYR0.7
HC4A1S4S0.7
HC4A1GSV0.7
HC4A2I9V0.7
HC4A2QWS0.7
HC4A1XFN0.7
HC4A1S4R0.7
HC4A1T180.7
HC4A1OTA0.7
HC4A1D7E0.7
HC4A1S1Z0.7
HC4A,B,C1MZU0.7
HC4A,B1ODV0.7
HC4A,B2J3J0.7
HC4A2QJ50.7
HC4A1OTB0.7
HC4A2D020.7
HC4A1OT90.7
HC4A1NWZ0.7
HC4A1S1Y0.7
F165-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-
ONE 1,1-DIOXIDE
A2CM80.7
SD2N-(SULFANYLACETYL)TYROSYLPROLYLMETHIONINAMIDEA,B1PWQ0.76
Y13(2E)-3-(3,4-DIHYDROXYPHENYL)-N-
[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE
A2EW60.76
NLTN-DODECANOYL-L-TYROSINEA,B,C,D,E,F,
G,H
2G0B0.7
SAF3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOLA1GQR0.7
SAF3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOLA1GQS0.7
GN8(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-
2-THIOXOTHIAZOLIDIN-4-ONE
A,B,C,D,E,F2P6F0.74